Fortis Capital Management LLC

Position in MRK — Merck & Co., Inc.

CIK 1802167 BELLEVUE, WA

Position in MRK

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$259,955

+$24,307 QoQ

Shares Held

2,023

+3.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#3,307

of 3,769 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Fortis Capital Management LLC holds $16,796,483 across 6 Drug Manufacturers - General names. MRK ranks #6 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	9,311	$11,167,893
2	ABBV	AbbVie Inc.	8,042	$2,023,688
3	JNJ	Johnson & Johnson	6,812	$1,730,043
4	AMGN	Amgen Inc	3,739	$1,353,966
5	NVS	Novartis AG	1,665	$260,938
6	MRK	Merck & Co., Inc. This page	2,023	$259,955

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$259,955	2,023	+3.3%	Shares	Sole	2026-08-13
2026-03-31	$235,648	1,959	-1.9%	Shares	Sole	2026-05-12
2025-12-31	$210,204	1,997	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.